PubRank

Barbara Burwinkel

Author PubWeight™ 157.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
2 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009 7.30
3 Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011 6.24
4 Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011 5.18
5 Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010 4.76
6 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
7 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
8 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
9 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 2009 2.88
10 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
11 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
12 First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008 1.98
13 Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 2013 1.88
14 SNPs in ultraconserved elements and familial breast cancer risk. Carcinogenesis 2008 1.84
15 Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012 1.82
16 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
17 SNP microarray analysis for genome-wide detection of crossover regions. Hum Genet 2005 1.68
18 Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol Nutr Food Res 2007 1.64
19 Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin Cancer Res 2012 1.63
20 Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 2012 1.61
21 MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev 2011 1.60
22 Identification of frequent chromosome copy-number polymorphisms by use of high-resolution single-nucleotide-polymorphism arrays. Am J Hum Genet 2006 1.60
23 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009 1.58
24 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
25 A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet 2013 1.52
26 Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 2012 1.51
27 Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 2010 1.45
28 A bias in genotyping the ERBB2 (HER2) Ile655Val variant. Carcinogenesis 2005 1.44
29 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
30 Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One 2013 1.39
31 Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol 2012 1.38
32 A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk. Breast Cancer Res Treat 2010 1.38
33 F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect 2013 1.37
34 Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 2008 1.36
35 A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 2009 1.30
36 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.29
37 CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 2012 1.29
38 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
39 The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat 2007 1.24
40 Aurora kinases A and B and familial breast cancer risk. Cancer Lett 2006 1.24
41 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
42 The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012 1.23
43 Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome. Am J Hum Genet 2012 1.21
44 Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 2007 1.20
45 Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 2005 1.17
46 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
47 SNP genotyping on a genome-wide amplified DOP-PCR template. Nucleic Acids Res 2002 1.13
48 A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2008 1.09
49 The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk. Carcinogenesis 2004 1.08
50 Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis 2010 1.08
51 Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer. Carcinogenesis 2006 1.07
52 Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. Front Genet 2013 1.07
53 Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients. Int J Cancer 2010 1.03
54 A breast cancer risk haplotype in the caspase-8 gene. Cancer Res 2009 1.03
55 Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 2010 1.01
56 The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer. Carcinogenesis 2006 1.00
57 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
58 Plasma microRNA panel for minimally invasive detection of breast cancer. PLoS One 2013 0.99
59 Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res 2014 0.99
60 Pancreatic cancer susceptibility loci and their role in survival. PLoS One 2011 0.98
61 A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults. Hepatology 2008 0.96
62 Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 2005 0.96
63 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012 0.95
64 Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. Carcinogenesis 2005 0.94
65 Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis 2006 0.93
66 Allelotyping of pooled DNA with 250 K SNP microarrays. BMC Genomics 2007 0.93
67 Variable number of tandem repeats polymorphism in the SMYD3 promoter region and the risk of familial breast cancer. Int J Cancer 2006 0.92
68 Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. Endocr Relat Cancer 2007 0.92
69 BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study. BMC Cancer 2007 0.92
70 The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain. J Med Genet 2011 0.91
71 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 2010 0.91
72 Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk. Int J Cancer 2006 0.91
73 Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis. Breast Cancer Res Treat 2014 0.91
74 Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer. Carcinogenesis 2006 0.91
75 Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. Hum Mutat 2010 0.90
76 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
77 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet 2014 0.89
78 ARLTS1 variants and risk of colorectal cancer. Cancer Lett 2006 0.89
79 Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. Carcinogenesis 2013 0.89
80 ARLTS1 variants and melanoma risk. Int J Cancer 2006 0.88
81 The functional genetic variant Arg324Gly of frizzled-related protein is associated with colorectal cancer risk. Carcinogenesis 2007 0.88
82 MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 2005 0.88
83 TP53-binding protein variants and breast cancer risk: a case-control study. Breast Cancer Res 2005 0.87
84 Copy number variation in patients with cervical artery dissection. Eur J Hum Genet 2012 0.87
85 Death receptor 4 variants and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2006 0.87
86 Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families. Cancer Lett 2008 0.87
87 Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat 2010 0.86
88 A bias in genotyping the miR-27a rs895819 and rs11671784 variants. Breast Cancer Res Treat 2012 0.86
89 Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. Cancer Epidemiol 2013 0.85
90 Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. Carcinogenesis 2005 0.85
91 The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer. Cancer Res 2006 0.85
92 Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab 2006 0.84
93 Familial cancer and ARLTS1. N Engl J Med 2005 0.84
94 Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients. BMC Cancer 2014 0.84
95 DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. Int J Cancer 2014 0.84
96 Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. BMC Cancer 2009 0.83
97 Isolation of circulating microRNA associated with RNA-binding protein. Methods Mol Biol 2013 0.83
98 Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults. Epidemiology 2013 0.82
99 CD24 polymorphisms in breast cancer: impact on prognosis and risk. Breast Cancer Res Treat 2013 0.81
100 A BRCA1 promoter variant (rs11655505) and breast cancer risk. J Med Genet 2010 0.81
101 Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk. Int J Cancer 2012 0.81
102 c-MYC Asn11Ser is associated with increased risk for familial breast cancer. Int J Cancer 2005 0.81
103 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet 2011 0.80
104 Molecular genetic analysis of NBS1 in German melanoma patients. Melanoma Res 2007 0.80
105 Identification of new acyl-CoA binding protein transcripts in human and mouse. Int J Biochem Cell Biol 2005 0.80
106 CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Res Treat 2011 0.80
107 Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One 2012 0.80
108 Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 2013 0.79
109 Trisomy 8q and partial trisomy 22 in a 43-year-old man with moderate intellectual disability, epilepsy and large cell non-Hodgkin lymphoma. Am J Med Genet A 2006 0.77
110 Polyglutamine repeat length in the NCOA3 does not affect risk in familial breast cancer. Cancer Epidemiol Biomarkers Prev 2005 0.76
111 Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations. Mol Nutr Food Res 2007 0.76
112 Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk. Breast Cancer Res Treat 2007 0.76
113 Arthrogryposis multiplex with deafness, inguinal hernias, and early death: a family report of a probably autosomal recessive trait. Am J Med Genet A 2005 0.75
114 Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk. Breast Cancer Res Treat 2009 0.75
115 Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance. Breast Cancer Res Treat 2014 0.75
116 Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene. Breast Cancer Res Treat 2012 0.75